Esomeprazole Magnesium + Lansoprazole
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Heartburn
Conditions
Heartburn, Gastroesophageal Reflux Disease
Trial Timeline
Jun 1, 2002 → Feb 1, 2003
NCT ID
NCT00637845About Esomeprazole Magnesium + Lansoprazole
Esomeprazole Magnesium + Lansoprazole is a approved stage product being developed by AstraZeneca for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00637845. Target conditions include Heartburn, Gastroesophageal Reflux Disease.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00637845 | Approved | Completed |
Competing Products
20 competing products in Heartburn